PerkinElmer, Inc. is the latest company to bolster its in-vitro diagnostics business with a buyout.
The company announced on 17 May it acquired UK-based Immunodiagnostics Systems Holdings PCL for about $155m in cash. PerkinElmer said the transaction has a total enterprise value of about $124m...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?